These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

386 related articles for article (PubMed ID: 18472213)

  • 1. Multitargeted therapy of cancer by silymarin.
    Ramasamy K; Agarwal R
    Cancer Lett; 2008 Oct; 269(2):352-62. PubMed ID: 18472213
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Silymarin (milk thistle extract) as a therapeutic agent in gastrointestinal cancer.
    Fallah M; Davoodvandi A; Nikmanzar S; Aghili S; Mirazimi SMA; Aschner M; Rashidian A; Hamblin MR; Chamanara M; Naghsh N; Mirzaei H
    Biomed Pharmacother; 2021 Oct; 142():112024. PubMed ID: 34399200
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Silymarin and hepatocellular carcinoma: a systematic, comprehensive, and critical review.
    Mastron JK; Siveen KS; Sethi G; Bishayee A
    Anticancer Drugs; 2015 Jun; 26(5):475-86. PubMed ID: 25603021
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toward the definition of the mechanism of action of silymarin: activities related to cellular protection from toxic damage induced by chemotherapy.
    Comelli MC; Mengs U; Schneider C; Prosdocimi M
    Integr Cancer Ther; 2007 Jun; 6(2):120-9. PubMed ID: 17548791
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Silibinin meglumine, a water-soluble form of milk thistle silymarin, is an orally active anti-cancer agent that impedes the epithelial-to-mesenchymal transition (EMT) in EGFR-mutant non-small-cell lung carcinoma cells.
    Cufí S; Bonavia R; Vazquez-Martin A; Corominas-Faja B; Oliveras-Ferraros C; Cuyàs E; Martin-Castillo B; Barrajón-Catalán E; Visa J; Segura-Carretero A; Bosch-Barrera J; Joven J; Micol V; Menendez JA
    Food Chem Toxicol; 2013 Oct; 60():360-8. PubMed ID: 23916468
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular mechanisms of inhibition of photocarcinogenesis by silymarin, a phytochemical from milk thistle (Silybum marianum L. Gaertn.) (Review).
    Vaid M; Katiyar SK
    Int J Oncol; 2010 May; 36(5):1053-60. PubMed ID: 20372777
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiproliferative and apoptotic effects of silibinin in rat prostate cancer cells.
    Tyagi A; Bhatia N; Condon MS; Bosland MC; Agarwal C; Agarwal R
    Prostate; 2002 Nov; 53(3):211-7. PubMed ID: 12386921
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Protective Effects of Silymarin on the Reproductive Toxicity: A Comprehensive Review.
    Hariyanti T; Margiana R; Al-Gazally ME; Patra I; Lateef Al-Awsi GR; Hameed N; Kayumova D; Ansari MJ; Torres-Criollo LM; Mustafa YF; Abedi-Firouzjah R; Farhood B
    Curr Med Chem; 2023; 30(39):4421-4449. PubMed ID: 36717999
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Silymarin and epithelial cancer chemoprevention: how close we are to bedside?
    Kaur M; Agarwal R
    Toxicol Appl Pharmacol; 2007 Nov; 224(3):350-9. PubMed ID: 17184801
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Flavonoid antioxidant silymarin and skin cancer.
    Singh RP; Agarwal R
    Antioxid Redox Signal; 2002 Aug; 4(4):655-63. PubMed ID: 12230878
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Silymarin antiproliferative and apoptotic effects: Insights into its clinical impact in various types of cancer.
    Hosseinabadi T; Lorigooini Z; Tabarzad M; Salehi B; Rodrigues CF; Martins N; Sharifi-Rad J
    Phytother Res; 2019 Nov; 33(11):2849-2861. PubMed ID: 31407422
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and Mechanisms of
    Ghahfarrokhi SH; Heidari-Soureshjani S; Sherwin CMT; Azadegan-Dehkordi Z
    Curr Rheumatol Rev; 2024; 20(4):414-425. PubMed ID: 38314596
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Silymarin is an ally against insulin resistance: A review.
    MacDonald-Ramos K; Michán L; Martínez-Ibarra A; Cerbón M
    Ann Hepatol; 2021; 23():100255. PubMed ID: 32950646
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Silymarin and skin cancer prevention: anti-inflammatory, antioxidant and immunomodulatory effects (Review).
    Katiyar SK
    Int J Oncol; 2005 Jan; 26(1):169-76. PubMed ID: 15586237
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The flavonolignan silibinin potentiates TRAIL-induced apoptosis in human colon adenocarcinoma and in derived TRAIL-resistant metastatic cells.
    Kauntz H; Bousserouel S; Gossé F; Raul F
    Apoptosis; 2012 Aug; 17(8):797-809. PubMed ID: 22555452
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A review of therapeutic potentials of milk thistle (
    Emadi SA; Ghasemzadeh Rahbardar M; Mehri S; Hosseinzadeh H
    Iran J Basic Med Sci; 2022 Oct; 25(10):1166-1176. PubMed ID: 36311193
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New therapeutic potentials of milk thistle (Silybum marianum).
    Milić N; Milosević N; Suvajdzić L; Zarkov M; Abenavoli L
    Nat Prod Commun; 2013 Dec; 8(12):1801-10. PubMed ID: 24555302
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [An updated review at molecular pharmacological level for the mechanism of anti-tumor, antioxidant and immunoregulatory action of silibinin].
    Wang HJ; Jiang YY; Lu P; Wang Q; Ikejima T
    Yao Xue Xue Bao; 2010 Apr; 45(4):413-21. PubMed ID: 21355204
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preventive effect of silymarin in cerebral ischemia-reperfusion-induced brain injury in rats possibly through impairing NF-κB and STAT-1 activation.
    Hou YC; Liou KT; Chern CM; Wang YH; Liao JF; Chang S; Chou YH; Shen YC
    Phytomedicine; 2010 Oct; 17(12):963-73. PubMed ID: 20833521
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Silychristin derivatives conjugated with coniferylalcohols from silymarin and their pancreatic α-amylase inhibitory activity.
    Kato E; Kushibiki N; Satoh H; Kawabata J
    Nat Prod Res; 2020 Mar; 34(6):759-765. PubMed ID: 30445852
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.